pH-responsive nanoparticles for cancer drug delivery

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Solid tumors exhibit an acidic extracellular environment and altered intracellular pH gradients.
• This unique tumor pH is a targetable characteristic for advanced cancer therapies.
• Conventional drug delivery systems lack specificity in these acidic tumor microenvironments.

Purpose of the Study:

• To explore the potential of pH-responsive nanoparticles for targeted cancer drug delivery.
• To investigate how nanoparticle design can leverage tumor-specific pH gradients.
• To compare the therapeutic advantages of pH-responsive versus pH-insensitive nanoparticles.

Main Methods:

• Development of nanoparticles with pH-sensitive coronas and/or cores.
• Designing coronas to alter charge or solubility at tumor extracellular pH for enhanced targeting.
• Engineering cores to release drugs in response to tumor extracellular or lysosomal pH.

Main Results:

• Developed nanoparticles with coronas that become positively charged or soluble at tumor pH, improving cellular targeting and internalization.
• Created nanoparticles with cores that solubilize or change structure at tumor pH, enabling rapid drug release.
• Demonstrated enhanced drug delivery and therapeutic potential compared to non-responsive nanoparticles.

Conclusions:

• pH-responsive nanoparticles are a promising strategy for overcoming challenges in cancer drug delivery.
• Leveraging tumor acidity through smart nanoparticle design enhances drug efficacy.
• These advanced nanoparticles offer significant therapeutic advantages over conventional systems.